Clinical Trials Directory

Trials / Completed

CompletedNCT07498790

Equal-Volume Pilates Frequency in Women With Overweight and Obesity

Effects of Equal-Volume Pilates Training Delivered at Different Weekly Frequencies on Functional Performance, Musculoskeletal Symptoms, and Quality of Life in Women With Overweight and Obesity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
51 (actual)
Sponsor
Pamukkale University · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn whether doing Pilates two days per week or three days per week leads to different health outcomes in women with overweight and obesity, when the total number of exercise sessions is the same. The study focuses on how these two Pilates schedules affect daily movement, balance, body measurements, and quality of life. The main questions it aims to answer are: When participants complete a total of thirty-six Pilates sessions, are there differences in functional performance between a program done three days per week for twelve weeks and a program done two days per week for eighteen weeks? Which program improves balance more? Which program improves obesity-related quality of life more? Are there differences between the two programs in waist and hip measurements, physical activity level, and musculoskeletal complaints? Researchers will compare two supervised Pilates programs: Pilates done three times per week for twelve weeks (thirty-six sessions total) Pilates done two times per week for eighteen weeks (thirty-six sessions total) Participants will: Be randomly assigned by computer to one of the two Pilates programs Take part in thirty-six supervised, mat-based Pilates sessions Have exercise intensity checked during sessions using the Borg Rating of Perceived Exertion scale Complete tests and measurements at the start and end of the study, such as walking and balance tests, body measurements, and questionnaires Be encouraged to walk at least two days per week on days without Pilates and record this activity in an exercise diary.

Detailed description

This randomized clinical trial was designed to examine whether the weekly frequency of supervised Pilates exercise influences functional, musculoskeletal, and quality of life outcomes in women with overweight and obesity when total exercise volume is held constant. Participants were allocated to one of two intervention groups using computer-generated randomization. One group completed a higher-frequency, shorter-duration program consisting of three supervised Pilates sessions per week over twelve weeks, while the other group completed a lower-frequency, longer-duration program consisting of two supervised sessions per week over eighteen weeks. Both groups completed an identical total of thirty-six supervised mat-based Pilates sessions, allowing exercise frequency and temporal distribution to be examined independently of total training dose. All Pilates sessions were delivered in a supervised group setting and followed a standardized and progressive protocol. Prior to the intervention, participants attended a familiarization session during which fundamental Pilates principles, including breathing control, core activation, postural alignment, and safe execution of exercises in different positions, were introduced. Each exercise session consisted of a warm-up period, a main Pilates exercise component, and a cool-down period. The program progressed in planned phases by gradually increasing exercise complexity and challenge through changes in body position, repetition number, holding time, and stability demands, while maintaining participant safety. Exercise intensity during sessions was monitored using the Borg Rating of Perceived Exertion (RPE) scale, with participants encouraged to remain within a moderate to moderately high perceived intensity range. Individual modifications and support were provided when necessary to accommodate physical limitations or discomfort and to ensure correct movement execution. In addition to the supervised Pilates sessions, participants in both groups were advised to engage in walking activity on at least two non-Pilates days per week. Adherence to both Pilates sessions and walking recommendations was monitored using an exercise diary, in which attendance, perceived exertion, and any exercise-related complaints were recorded. Outcome assessments were conducted at baseline and after completion of the intervention period by the same physiotherapist to ensure consistency. Assessments focused on functional performance, balance, anthropometric measures, physical activity level, musculoskeletal symptoms, and obesity-specific quality of life, using validated performance tests and self-reported questionnaires. The rationale for this study was based on evidence suggesting that total training volume is a primary determinant of exercise adaptation, while the independent contribution of weekly frequency remains unclear, particularly for low-impact, neuromuscular-focused exercise modalities such as Pilates. Individuals with overweight and obesity may also experience altered recovery capacity and musculoskeletal burden, making the optimal distribution of exercise sessions clinically relevant. By equating total supervised exercise volume, this study aimed to clarify whether distributing the same exercise dose across different weekly schedules results in distinct functional or quality-of-life outcomes. This study was conducted in accordance with ethical principles for research involving human participants, and all participants provided written informed consent prior to participation.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPilates ExerciseSupervised mat-based Pilates exercise program designed to improve core stabilization, postural alignment, balance, and controlled movement patterns. Sessions were delivered in a group setting and progressed gradually in difficulty. Exercise intensity was monitored using the Borg Rating of Perceived Exertion scale to maintain moderate to moderately high intensity.

Timeline

Start date
2023-09-11
Primary completion
2023-12-15
Completion
2024-04-26
First posted
2026-03-27
Last updated
2026-03-27

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07498790. Inclusion in this directory is not an endorsement.